Antibiotic susceptibility of Streptococcus pneumoniae, causing meningitis in Moscow


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. Determination of antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with pneumococcal meningitis in Moscow. Materials and methods. For the period 2006-2017, 99 strains were studied. The susceptibility of Streptococcus pneumoniae to a number of antibacterial drugs was established by the E-tests and diffusion test. Results. The level of resistance to benzylpenicillin was 5.1%, to erythromycin - 11.1%. The proportion of multiresistant strains was determined at the level of 6.1%. An increase in the susceptibility potential of pneumococcus to benzypenicillin, trimethoprim-sulfamethoxazole, levofloxacin, ceftriaxone was noted. On the contrary, an increase in the strains potential of resistance to macrolides and tetracycline was revealed. In relation to the serotype landscape of resistant strains, serotypes included in the 13-valent conjugated pneumococcal vaccine: 6B, 19F, 3, 23F, 18C and 19F, 14, 6A, 23F, 7F, respectively, prevailed both in the pre-vaccination and the post-vaccination period. Conclusion. Considering the increasing incidence of pneumococcal meningitis, high mortality rates, as well as the development of antibacterial resistance mechanisms in pneumococcal strains, there is a growing need to increase vaccination coverage of children to the targeted indicator and expand immunization programs against pneumococcal infection.

Full Text

Restricted Access

About the authors

Maria A. Koroleva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: korolevamaria389@gmail.com
Cand. Med. Sci., Senior Researcher, Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis

Irina S. Koroleva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: irina-korol@yandex.ru
MD, Head, Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis

Grigoriy V. Beloshitsky

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: g-belosh1@yandex.ru
Cand. Med. Sci., Senior Researcher, Laboratory for Epidemiology of Meningococcal Infection and Purulent Bacterial Meningitis

Irina M. Gruber

I.I. Mechnikov Research Institute of Vaccines and Sera

Email: igruber_instmach@mail.ru
MD, Head, Laboratory of Experimental Microbiology

References

  1. Musher D.M. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 1992; 14: 801-7.
  2. Klugman K.P. Pneumococcal resistance to Antibiotics. Clin. Microbiol. Rev. 1990; 3(2): 171-96.
  3. Jacobs M.R., Good C.E., Beall B., Bajaksouzian S., Windau A.R., Whitney C.G. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J. Clin. Microbiol. 2008; 46: 982-90.
  4. Klugman K.P., Lonks J.R. Hidden epidemic of macrolide-resistant pneumococci. Emerg. Infect. Dis. 2005; 1: 802-7.
  5. Imohl M., Reinert R.R., van der Linden M. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany. Int. J. Med. Microbiol. 2015; 305(7): 776-83.
  6. Королева И.С., Королева М.А., Белошицкий Г.В. Менингококковая инфекция и гнойные бактериальные менингиты в Российской Федерации. 2017. Информационно-аналитический обзор. М., 2018; 27-32.
  7. Королева И.С., Белошицкий Г.В. Менингококковая инфекция и гнойные бактериальные менингиты. Руководство по лабораторной диагностике. М.: Медицинское информационное агентство, 2007. 112 с.
  8. Weil-Oliver C., van der Linden M., de Schutter I., Dagan R., Mantovani L. Prevention of pneumococcal diseases in the postseven valent vaccine era: a European perspective. BMC Infect. Dis. 2012; 12: 207.
  9. Mokaddas E., Albert M.J., Impact of pneumococcal conjugate vaccine on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Vaccine 2012; 30(6): 37-40.
  10. Regev-Yochay G., Rahav G., Riesenberg K. et al. Initial effects of the national PCV7 childhood immunization program on adult invasive pneumococcal disease in Israel. PloS ONE 2014 (9): e88406. DOI: 10.1371/ journal.pone.0088406
  11. Lai C.C., Lin S.H., Liao C.H., Sheng W.H., Hsueh P.R. Decline in the incidence of invasive pneumococcal disease at medical center in Taiwan, 2000-2012. BMC Infect. Dis. 2014; 14: 76. https://doi. org/10.1186/1471-2334-14-76

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies